Leerink Partners Reaffirms Their Buy Rating on Ligand Pharma (LGND)
at www.tipranks.com (Mon, 2-Nov 11:43 AM)
RBC Capital Sticks to Its Buy Rating for Ligand Pharma (LGND)
at www.tipranks.com (Mon, 2-Nov 10:28 AM)
Royalty Buyout Options Pose Revenue and Cash-Flow Risks for Ligand Pharmaceuticals
at www.tipranks.com (Sun, 1-Nov 1:00 AM)
Ligand Pharma (LGND) Gets a Buy from Bank of America Securities
at www.tipranks.com (Fri, 30-Oct 12:56 PM)
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Kymera Therapeutics (KYMR)
at www.tipranks.com (Fri, 30-Oct 6:50 AM)
at www.tipranks.com (Fri, 30-Oct 6:01 AM)
